CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Jafron Biomedical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Jafron Biomedical Co Ltd
No. 98 Keji 6th Road, High-tech District
Phone: +86 7563619693p:+86 7563619693 ZHUHAI, GNG  519085  China Ticker: 300529300529
Business Summary
Jafron Biomedical Co Ltd is a China-based company principally engaged in the research, development, production and sales of biomaterials and high-tech medical devices. The Company is mainly engaged in the provision of blood purification products, disposable blood perfusion device, disposable plasma bilirubin adsorber, deoxyribonucleic acid (DNA) immunosorbent columns, cytokine adsorption column, haemodialysis powder, blood purification equipment and other products. The Company's products are widely used in the treatment of uremia, poisoning, severe liver disease, autoimmune diseases and multi-organ failure. The Company mainly conducts its businesses in the domestic market and overseas markets.
(Source: F-4)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
3845 Electromedical and electrotherapeutic apparatus
3841 Surgical and medical instruments and apparatus
6411 Insurance agents, brokers, and service

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, General Manager FanDong 54 9/29/2022 12/1/2010
Chief Financial Officer, Director XueyunLiao 47 12/27/2023 4/24/2023
Deputy General Manager, Director XianminTang 54 12/27/2010 12/27/2010
9 additional Officers and Directors records available in full report.

General Information
Number of Employees: 2,408 (As of 12/31/2023)
Outstanding Shares: 798,605,275 (As of 9/30/2024)
Shareholders: 57,630
Stock Exchange: SHE
Fax Number: +86 7563619373


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, December 3, 2024